We report increased numbers of hematogones in a 7-year-old girl with pancytopenia due to Shwachman-Diamond syndrome. Her hematogones expressed the T-cell marker CD5 as well as CD19, CD10, and CD20, and terminal deoxynucleotidyl transferase and HLA-DR. These findings suggest that hematogones are precursors of both CD5-positive B cells and CD5-negative B cells. Thus CD5-positive B cells in bone marrow may be derived from bone marrow stem cells, and not from the residual fetal B cells of yolk sac/liver origin. The finding of CD5 expression on hematogones also raises the possibility that neoplastic B cells of chronic lymphocytic leukemia, which characteristically co-express CD5 and CD19, may be derived from CD5-positive B-cell precursors in bone marrow and not from mature B cells in lymph nodes.
LongacreTA, FoucarK, CragoS, Hematogones: a multiparameter analysis of bone marrow precursor cells. Blood.1989;73:543–552.
3.
KluppN, SimonitschI, MannhalterC, Emergence of an unusual bone marrow precursor B-cell population in fatal Shwachman-Diamond syndrome. Arch Pathol Lab Med2000;124:1379–1381.
4.
VogelP, ErfLA, RosentalN.Hematological observations on bone marrow obtained by sternal puncture. Am J Clin Pathol1937;7:436–447.
5.
VogelP, BassenF.Sternal marrow of children in normal and pathologic states. Am J Dis Child1939;57:245–268.
6.
CaldwellCW, PojeE, HeliksonMA. B-cell precursors in normal pediatric bone marrow. Am J Clin Pathol1991;95:816–823.
7.
RimszaLM, LarsonRS, WinterSS, Benign hematogone-rich lymphoid proliferation can be distinguished from B-lineage acute lymphoblastic leukemia by integration of morphology, immunophenotype, adhesion molecule expression, and architectural features. Am J Clin Pathol2000;114:66–75.
8.
RimszaLM, ViswanathaDS, WinterSS, The presence of CD34+ cell clusters predict impending relapse in children with acute lymphoblastic leukemia receiving maintenance chemotherapy. Am J Clin Pathol1998;110:313–320.
9.
DavisRE, LongacreTA, CornbleetPJ. Hematogones in the bone marrow of adults. Immunophenotypic features, clinical settings, and differential diagnosis. Am J Clin Pathol1994;102:202–211.
10.
SolvasonN, LehuenA, KearneyJF. An embryonic source of Ly1 but not conventional B cells. Int Immunol1991;3:543–550.
11.
YouinouP, JaminC, LydyardPM. CD5 expression in human B-cell populations. Immunol Today1999;20:312–316.
12.
LydyardPM, Quartey-PapafioRP, BrokerBM, The antibody repertoire of early human B cells. I. High frequency of autoreactivity and polyreactivity. Scand J Immunol1990;31:33–43.
13.
NovelliE, RamirezM, LeungW, Human hematopoietic stem/progenitor cells generate CD5+ B lymphoid cells in NOD/SCID mice. Stem Cells1999;17:242–252.
14.
NisitaniS, NurakamiM, AkamizuT, Preferential localization of human CD5+ B-cells in the peritoneal cavity. Scand J Immunol1997;46:541–545.
15.
MillerRA, GralowJ.The induction of Leu-1 antigen expression in human malignant and normal B cells by phorbol myristic acetate (PMA). J Immunol1984;133:3408–3414.
16.
CongYZ, RabinE, WortisHH. Treatment of murine CD5+ B-cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways. Int Immunol1991;3:467–476.
17.
TalalN, DauphineM, AhmedSA. CD5 cells in autoimmunity. Ann N Y Acad Sci1992;651:551–556.
18.
Plater-ZyberkC, BrownCMS, AndrewEM, CD5+ B-cells in rheumatoid arthritis. Ann N Y Acad Sci1992; 651:540–550.
19.
ChanEY, LawtonJW, LieAK, Autoantibody formation after allogenic bone marrow transplantation: correlation with the reconstitution of CD5+ B-cells and occurrence of graft versus host disease. Pathology1997;29:184–188.
20.
BombergerC, Singh-JairamM, RodeyG, Lymphoid reconstitution after autologous PBSC transplantation with FACS-sorted CD34+ hematopoietic progenitors. Blood1998;91:2588–2600.
21.
TaniguchiM, OkaK, HiasaA, De novo CD5+ diffuse large B-cell lymphomas express VH genes with somatic mutation. Blood1998;91:1145–1151.
22.
HuangCA, HenryC, IacominiJ, Adult bone marrow contains precursors for CD5+ B-cells. Eur J Immunol1996;26:2537–2540.
23.
AntinJH, AultKA, RappeportJM, B lymphocytes reconstitution after human bone marrow transplantation. Leu-1 antigen defines a distinct population of B lymphocytes. J Clin Invest1987;80:325–332.
GahrM, SchroterW.The pattern of reactivated fetal erythropoiesis in bone marrow disorders of childhood. Acta Paediatr Scand1982;71:1013–1018.
26.
AlterBP. Fetal erythopoiesis in stress hematopoiesis. Exp Hematol1979;Suppl 5:200–209.
27.
LinkMP, AlterBP. Fetal-like erythropoiesis during recovery from transient erythroblastopenia of childhood. Pediatr Res1981;15:1036–1039.
28.
PangalisGA, AngelopoulouMK, VassilakopoulosTP, B-chronic lymphocytic leukemia, small lymphocytic leukemia, and lymphoplasmacytic lymphoma, including Waldenstrom's macroglobulinema: a clinical, morphologic, and biologic spectrum of similar disorders. Semin Hematol1999;2:104–114.
29.
HamblinTJ, DavisZ, GardinerA, Unmutated Ig V (H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood1999;94:1837–1839.
